Published in Food and Drug Law Weekly, August 3rd, 2007
"Without natalizumab, European patients with severely active disease who failed other therapies and who are suffering from continuous symptoms may be...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Food and Drug Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.